Published online July 1, 2008
PEDIATRICS Vol. 122 No. 1 July 2008, pp. e26-e32 (doi:10.1542/peds.2007-1510)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hjuler, T.
Right arrow Articles by Melbye, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hjuler, T.
Right arrow Articles by Melbye, M.
Related Collections
Right arrow Infectious Disease & Immunity
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Risks of Invasive Pneumococcal Disease in Children With Underlying Chronic Diseases

Thomas Hjuler, MD, PhDa, Jan Wohlfahrt, MSc, DMSca, Margit Staum Kaltoft, MD, PhDb, Anders Koch, MD, PhDa, Robert John Biggar, MDa,c and Mads Melbye, MD, DMSca

a Departments of Epidemiology Research
b Bacteriology, Mycology, and Parasitology, Statens Serum Institut, Copenhagen, Denmark
c Viral Epidemiology Branch, Division of Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland

OBJECTIVE. The risk of invasive pneumococcal disease is increased among children with some chronic diseases. The objective of this study was to quantify the risk of invasive pneumococcal disease in a wide range of chronic diseases.

PATIENTS AND METHODS. Cases of invasive pneumococcal disease among children (aged 0–17 years) were identified from 1977 through 2005 by using a national surveillance program in Denmark. Rate ratios were assessed in a case-control study by using 10 age- and gender-matched controls per case. Chronic diseases were defined a priori.

RESULTS. Among 1655 children with invasive pneumococcal disease, 19% had a history of chronic disease, according to our definition, versus 5% of controls. An increased risk of invasive pneumococcal disease was observed for children followed >30 days after initial hospital contact for a chronic disease, but it was also increased in children with ≥5 hospital contacts for any other reason. Children with a history of cancer, chronic renal disease, splenectomy, and transplantation were particularly susceptible to invasive pneumococcal disease. Adjusted for number of hospital contacts, the risk for children with other types of chronic disease was 1.4-fold more than for those with hospital contacts for any reason.

CONCLUSIONS. Cancer, chronic renal diseases, splenectomy, and transplantation were strongly associated with an increased risk of invasive pneumococcal disease in children. For children with other chronic diseases, their excess risk seemed to be attributable mostly to frail children having repeated hospital contact rather than their underlying condition.

Key Words: pneumococcal infections • epidemiology • comorbidity • invasive procedures • disease susceptibility • case-control studies

Abbreviations: IPD—invasive pneumococcal disease • RR—rate ratio • CNS—central nervous system • ICD—International Classification of Diseases • CI—confidence interval • aRR—adjusted rate ratio

Accepted Jan 17, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Am J EpidemiolHome page
T. Hjuler, G. Poulsen, J. Wohlfahrt, M. Kaltoft, R. J. Biggar, and M. Melbye
THE AUTHORS REPLY
Am. J. Epidemiol., October 15, 2008; 168(8): 976 - 976.
[Full Text] [PDF]